These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments. Fiore MC; Kenford SL; Jorenby DE; Wetter DW; Smith SS; Baker TB Chest; 1994 Feb; 105(2):524-33. PubMed ID: 8306757 [TBL] [Abstract][Full Text] [Related]
4. Escalating doses of transdermal nicotine in heavy smokers: effects on smoking behavior and craving. Selby P; Andriash K; Zawertailo L; Persad D; Zack M; Busto UE J Clin Psychopharmacol; 2013 Oct; 33(5):667-74. PubMed ID: 23963055 [TBL] [Abstract][Full Text] [Related]
5. The transdermal nicotine patch: results of a randomised placebo-controlled trial. Richmond RL; Harris K; de Almeida Neto A Med J Aust; 1994 Jul; 161(2):130-5. PubMed ID: 8028537 [TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blind, placebo-controlled study of transdermal nicotine patch for smoking cessation. Perng RP; Hsieh WC; Chen YM; Lu CC; Chiang SJ J Formos Med Assoc; 1998 Aug; 97(8):547-51. PubMed ID: 9747065 [TBL] [Abstract][Full Text] [Related]
7. Predicting smoking cessation. Who will quit with and without the nicotine patch. Kenford SL; Fiore MC; Jorenby DE; Smith SS; Wetter D; Baker TB JAMA; 1994 Feb; 271(8):589-94. PubMed ID: 8301790 [TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetic model of transdermal nicotine delivered from a matrix-type patch. Linakis MW; Rower JE; Roberts JK; Miller EI; Wilkins DG; Sherwin CMT Br J Clin Pharmacol; 2017 Dec; 83(12):2709-2717. PubMed ID: 28771779 [TBL] [Abstract][Full Text] [Related]
9. Determinants of plasma concentrations of nicotine and cotinine during cigarette smoking and transdermal nicotine treatment. Gourlay SG; Benowitz NL; Forbes A; McNeil JJ Eur J Clin Pharmacol; 1997; 51(5):407-14. PubMed ID: 9049583 [TBL] [Abstract][Full Text] [Related]
10. Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind study. Daughton DM; Heatley SA; Prendergast JJ; Causey D; Knowles M; Rolf CN; Cheney RA; Hatlelid K; Thompson AB; Rennard SI Arch Intern Med; 1991 Apr; 151(4):749-52. PubMed ID: 2012458 [TBL] [Abstract][Full Text] [Related]
11. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement. Hurt RD; Dale LC; Fredrickson PA; Caldwell CC; Lee GA; Offord KP; Lauger GG; Marŭsić Z; Neese LW; Lundberg TG JAMA; 1994 Feb; 271(8):595-600. PubMed ID: 8301791 [TBL] [Abstract][Full Text] [Related]
12. A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. Tønnesen P; Nørregaard J; Simonsen K; Säwe U N Engl J Med; 1991 Aug; 325(5):311-5. PubMed ID: 2057036 [TBL] [Abstract][Full Text] [Related]
13. Transdermal nicotine and smoking behavior in psychiatric patients. Hartman N; Leong GB; Glynn SM; Wilkins JN; Jarvik ME Am J Psychiatry; 1991 Mar; 148(3):374-5. PubMed ID: 1992843 [TBL] [Abstract][Full Text] [Related]